FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * NOONAN TERRENCE A   2. Issuer Name and Ticker or Trading Symbol ENDOCARE INC [ENDO] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner _____ Officer (give title below) __X__ Other (specify below) Former Director (Last) (First) (Middle) C/O ENDOCARE, INC., 201 TECHNOLOGY DRIVE 3. Date of Earliest Transaction (Month/Day/Year) 04/06/2009 (Street) IRVINE, CA 92618 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock (1) 04/06/2009   M   16,669 (1) A (1) 16,669 D   Common Stock (2) 04/06/2009   M   9,203 (2) A (2) 25,872 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code (Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date (Month/Day/Year)

7. Title and Amount of Underlying Securities (Instr. 3 and 4)

8. Price of Derivative Security (Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)

11. Nature of Indirect Beneficial Ownership (Instr. 4)

Code

V

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Deferred Stock Units (3)

(3)

04/06/2009

M

16,669

04/06/2009

04/06/2009

Common Stock

16,669

(3)

24,141 (4)

D

Restricted Stock Units (5)

(5)

04/06/2009

M

9,203

04/06/2009

04/06/2009

Common Stock

9,203

(5)

0

D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
NOONAN TERRENCE A C/O ENDOCARE, INC. 201 TECHNOLOGY DRIVE IRVINE, CA 92618				Former Director

Signatures

/s/ Clint B. Davis, as attorney-in-fact		04/08/2009
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	April 6, 2009 was the "payout date" for a total of 16,669 shares underlying Mr. Noonan's deferred stock units (DSUs), as a result of Mr. Noonan's resignation from Endocare's Board of Directors on that date.
(2)	April 6, 2009 was the "payout date" for a total of 9,203 shares underlying Mr. Noonan's restricted stock units (RSUs), as a result of Mr. Noonan's resignation from Endocare's Board of Directors on that date. 2,061 of these RSUs were vested prior to Mr. Noonan's resignation. The Board of Directors decided to accelerate the vesting of the remaining 7,142 RSUs upon Mr. Noonan's resignation. These 7,142 RSUs would otherwise have vested on May 15, 2009.
(3)	Each DSU reflects the right to receive one share of Endocare's common stock upon the "payout date" applicable to such DSU.
(4)	The shares underlying the remaining 24,141 DSUs are to be issued on December 31, 2009.
(5)	Each RSU reflects the right to receive one share of Endocare's common stock upon the "payout date" applicable to such RSU.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.